Skip to content

Effect of different vision aids on low vision patients

Effect of different vision aids on low vision patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000028859
Enrollment
Unknown
Registered
2020-01-05
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low vision

Interventions

A:each patient wear different vision aids separately
B: each patient wear different vision aids separately

Sponsors

EYE & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In this study, we selected patients with good general body conditions and voluntary participation, who were able to cooperate well and fill out informed consent forms in the low vision clinic of EYE & ENT Hospital of Fudan University. The selected patients were divided into two groups: the central visual impairment group and the peripheral visual field defect group. Group A: Central vision impairment group: patients with BCVA of the better eyes less than 0.3 and better than light sense. According to China's 1987 classification of low vision and blindness, they are divided into first-level blindness, second-level blindness, first-level low vision and secondary low vision, about 10 people in each group. Group B: peripheral visual field defect group: (1) tunnel vision group: the residual visual field diameter is less than 20 degree. These patients are divided into 3 groups: Group I: visual field diameter in the range of 10 to 20 degree (about 20 people); Group II: visual field diameter in the range of 5 ~10 degree (about 20 people); Group III: The diameter of the field of view is less than 5 degree (about 20 people); (2) Hemianopsia group: these patients are divided into 2 groups: Group?: Temporal hemianopia group (about 10 people); Group II: Nasal hemianopia group (about 10 people); 3. Other types of severe visual field defects: including temporal islands and so on (about 20 people).

Exclusion criteria

Exclusion criteria: Patients with unstable primary disease or systemic disease affecting the study

Design outcomes

Primary

MeasureTime frame
visual field;visual acuity;vision related quality of life;mobilty;reading ability;

Contacts

Public ContactJinhui Dai

EYE & ENT Hospital of Fudan University

daijinhui8@126.com+86 18917785089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026